)
Edge1 May 2026
Making the Marlboro Man
The story of Marlboro's transformation from a women's cigarette to a global icon: one of the most effective brand repositionings in history.
ARS Pharmaceuticals
ARS Pharmaceuticals (SPRY) investor relations material
ARS Pharmaceuticals Proxy filing summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Proxy filing summary29 Apr, 2026
Executive summary
Annual meeting scheduled for June 24, 2026, to be held virtually for shareholders of record as of April 27, 2026.
Proxy materials, including the notice, proxy statement, and annual report, are available online, with paper copies available upon request.
Voting matters and shareholder proposals
Election of three Class III director nominees to serve three-year terms until the 2029 annual meeting.
Ratification of Ernst & Young LLP as independent auditor for the fiscal year ending December 31, 2026.
Advisory vote on executive compensation (say-on-pay) and on the frequency of future say-on-pay votes.
Board recommends voting for all proposals and holding say-on-pay votes every year.
Provision to conduct any other business properly brought before the meeting.
Board of directors and corporate governance
Nominees for Class III director are Saqib Islam, J.D., Phillip Schneider, and Laura Shawver, Ph.D.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from ARS Pharmaceuticals
- Commercial launch success, robust financials, and key governance votes highlight this year's proxy.SPRY
Proxy filing29 Apr 2026 - Expanding neffy access, advancing urticaria trials, and strong global uptake drive future growth.SPRYLeerink Global Healthcare Conference 202611 Mar 2026
- $84.3M revenue, 93% coverage, global expansion, and $171.3M net loss in 2025.SPRYQ4 202510 Mar 2026
- neffy’s needle-free nasal spray is transforming emergency allergy care and driving rapid market growth.SPRYCorporate presentation9 Mar 2026
- FDA approved a needle-free epinephrine nasal spray for emergency allergic reactions.SPRYFDA Announcement2 Feb 2026
- neffy’s launch drives early revenue, global expansion, and strong cash position.SPRYQ3 202414 Jan 2026
- Neffy’s launch accelerates with robust physician uptake, payer access, and pipeline expansion.SPRYGuggenheim Securities Inaugural Healthcare Innovation Conference14 Jan 2026
- neffy’s U.S. launch accelerates, targeting broad adoption and market expansion with strong IP protection.SPRYStifel 2024 Healthcare Conference13 Jan 2026
- Needle-free epinephrine spray is rapidly gaining adoption and poised for blockbuster growth.SPRY43rd Annual J.P. Morgan Healthcare Conference 202510 Jan 2026
Next ARS Pharmaceuticals earnings date
Q1 202613 May, 2026
ARS Pharmaceuticals
Next ARS Pharmaceuticals earnings date
Q1 202613 May, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Explore our global coverage